Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,819 | 491 | 92.6% |
| Honoraria | $540.00 | 1 | 3.9% |
| Education | $486.94 | 5 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,055 | 33 | $0 (2024) |
| Incyte Corporation | $1,010 | 41 | $0 (2024) |
| Celgene Corporation | $778.05 | 36 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $761.24 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $735.63 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $727.10 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $629.27 | 16 | $0 (2024) |
| PFIZER INC. | $566.51 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $562.60 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $462.16 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,243 | 154 | Incyte Corporation ($367.00) |
| 2023 | $3,370 | 127 | AstraZeneca Pharmaceuticals LP ($447.33) |
| 2022 | $3,193 | 119 | Celgene Corporation ($344.62) |
| 2021 | $3,022 | 96 | Karyopharm Therapeutics Inc. ($665.00) |
| 2018 | $18.52 | 1 | APO-PHARMA USA, INC. ($18.52) |
All Payment Transactions
497 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Oncology | ||||||
| 12/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/16/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/16/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $2.23 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 12/05/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $133.29 | General |
| Category: Oncology | ||||||
| 12/05/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Oncology | ||||||
| 12/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $27.97 | General |
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: BioOncology | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Oncology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 11/04/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $28.43 | General |
| 11/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: ONCOLOGY | ||||||
About Sharon Westerberg, PA-C
Sharon Westerberg, PA-C is a Hematology & Oncology healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629097191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sharon Westerberg, PA-C has received a total of $13,846 in payments from pharmaceutical and medical device companies, with $4,243 received in 2024. These payments were reported across 497 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($12,819).
Practice Information
- Specialty Hematology & Oncology
- Location Anaheim, CA
- Active Since 07/18/2006
- Last Updated 03/18/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1629097191
Products in Payments
- XPOVIO (Drug) $761.24
- Pomalyst (Drug) $548.01
- Trodelvy (Drug) $497.94
- JAKAFI (Drug) $481.79
- Lenvima (Drug) $408.32
- MONJUVI (Drug) $376.01
- KEYTRUDA (Biological) $340.86
- REBLOZYL (Biological) $339.60
- CALQUENCE (Drug) $307.32
- LIBTAYO (Biological) $286.72
- DARZALEX (Biological) $281.91
- LYNPARZA (Drug) $275.06
- Nubeqa (Drug) $273.41
- IBRANCE (Drug) $243.93
- ADCETRIS (Biological) $230.41
- VERZENIO (Drug) $223.59
- ENHERTU (Biological) $200.75
- BRUKINSA (Drug) $195.72
- FRUZAQLA (Drug) $192.85
- Udenyca (Biological) $192.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Anaheim
Dr. Nawid Sarwari, M.d, M.D
Hematology & Oncology — Payments: $28,276
Dr. Jayaram Bharadwaj, M.d, M.D
Hematology & Oncology — Payments: $19,683
Dr. Baijia Jiang, M.d, M.D
Hematology & Oncology — Payments: $10,554
Dr. Van Nguyen, M.d, M.D
Hematology & Oncology — Payments: $1,102
Farah Brasfield, Md, MD
Hematology & Oncology — Payments: $935.00
Dr. Charng Chong, M.d, M.D
Hematology & Oncology — Payments: $504.53